What is Zacks Research’s Forecast for ACAD FY2025 Earnings?
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD – Free Report) – Zacks Research decreased their FY2025 EPS estimates for shares of ACADIA Pharmaceuticals in a report issued on Wednesday, May 28th. Zacks Research analyst A. Chakraborty now expects that the biopharmaceutical company will post earnings of $0.51 per share for the year, down from their prior estimate of […]
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD – Free Report) – Zacks Research decreased their FY2025 EPS estimates for shares of ACADIA Pharmaceuticals in a report issued on Wednesday, May 28th. Zacks Research analyst A. Chakraborty now expects that the biopharmaceutical company will post earnings of $0.51 per share for the year, down from their prior estimate of […]
